Preoperative/neoadjuvant medical therapy for early breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
1998 • 2,115 citations
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
1999 • 1,315 citations
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
2001 • 1,019 citations
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
2000 • 990 citations
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
2000 • 841 citations
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
1998 • 581 citations
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
1988 • 511 citations
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
1994 • 435 citations
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
1999 • 433 citations
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
1995 • 348 citations
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
1998 • 322 citations
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm
1991 • 277 citations
Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer
1978 • 275 citations
Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer
1990 • 267 citations
Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer
1999 • 253 citations
Multimodal treatment of locoregionally advanced breast cancer
1983 • 246 citations
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
1994 • 208 citations
Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone
1991 • 193 citations
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.
1995 • 186 citations
Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.
1982 • 184 citations
PROSPECTIVE RANDOMISED TRIAL OF TAMOXIFEN VERSUS SURGERY IN ELDERLY PATIENTS WITH BREAST CANCER
1988 • 159 citations
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
1997 • 156 citations
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.
2000 • 148 citations
Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.
1988 • 145 citations
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
2000 • 128 citations
Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial
1999 • 124 citations
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
1998 • 117 citations
Primary medical (neo-adjuvant) chemotherapy for operable breast cancer
1993 • 104 citations
A Personal Experience with Halstedʼs Radical Mastectomy
1984 • 81 citations
Primary systemic therapy for operable breast cancer
1991 • 78 citations
Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy
1997 • 74 citations
A HUMAN TUMOUR MODEL
1986 • 74 citations
Proliferating Fraction During Neoadjuvant Chemotherapy of Primary Breast Cancer in Relation to Objective Local Response and Relapse-free Survival
1999 • 60 citations
Primary medical therapy for operable breast cancer
1989 • 48 citations
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy
2000 • 41 citations
Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy
2000 • 34 citations
Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis
1999 • 26 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database